AGP Picks
View all

Health Press Bhutan
Provided by AGP

Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 21, 2026

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
31 minutes ago

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

Indeterminate GlobeNewswire
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
31 minutes ago

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Indeterminate GlobeNewswire
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
31 minutes ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Indeterminate GlobeNewswire
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
31 minutes ago

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Indeterminate GlobeNewswire
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
31 minutes ago

Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®

Indeterminate GlobeNewswire
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
36 minutes ago

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
an hour ago

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Indeterminate GlobeNewswire
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
an hour ago

Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types

Indeterminate GlobeNewswire
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
an hour ago

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication
an hour ago

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Indeterminate GlobeNewswire
Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange
an hour ago

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

Indeterminate GlobeNewswire
R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis
an hour ago

R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis

Indeterminate GlobeNewswire
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
an hour ago

PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002

Indeterminate GlobeNewswire
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
an hour ago

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Indeterminate GlobeNewswire
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
an hour ago

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

Indeterminate GlobeNewswire
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
an hour ago

Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease

Indeterminate GlobeNewswire
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
an hour ago

Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire
OKYO Pharma Announces Purchase of Shares by Chairman
an hour ago

OKYO Pharma Announces Purchase of Shares by Chairman

Indeterminate GlobeNewswire
BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt
an hour ago

BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt

Indeterminate GlobeNewswire
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
an hour ago

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Press Bhutan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.